Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05242770 · ClinicalTrials.gov registry record · NA
Pelvic Physical Therapy for Sexual Dysfunction in Gynecologic Oncology Survivors
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05242770: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT05242770 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05242770, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this research study is to investigate the use of pelvic physical therapy for gynecologic cancer survivors who report sexual dysfunction. Physical therapy experts believe that a full 10-week regimen is necessary for true improvement of symptoms. Investigators aim to see if this tense regimen is feasible for survivors. Investigators also aim to see if patients have an improvement in their sexual function and quality of life.
Primary Outcome
Accrual is the number of participants that screen positive for sexual dysfunction, are eligible for entry into the study and consent to participate in the study.
Interventions
- OTHER Control Arm
- OTHER Physical Therapy Arm
- OTHER European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30)
- OTHER Female Sexual Function Index (FSFI)
- OTHER Exit Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2022-09-14 |
| Phase | NA |
What the finished NCT05242770 record still lists
NCT05242770 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Control Arm is the first listed.
NCT05242770 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05242770 about?
NCT05242770 is a clinical study titled "Pelvic Physical Therapy for Sexual Dysfunction in Gynecologic Oncology Survivors". The purpose of this research study is to investigate the use of pelvic physical therapy for gynecologic cancer survivors who report sexual dysfunction. Physical therapy experts believe that a full 10-week regimen is necessary for true improvement of symptoms. Investigators aim to see if this tense r...
What is the current status of trial NCT05242770?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-03-28. Estimated completion is 2022-09-14.
What interventions are being tested in trial NCT05242770?
The interventions under investigation include: Control Arm (OTHER), Physical Therapy Arm (OTHER), European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30) (OTHER), Female Sexual Function Index (FSFI) (OTHER), Exit Interview (OTHER).
Who is sponsoring clinical trial NCT05242770?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05242770's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI